Proposed Data Collections Submitted for Public Comment and Recommendations, 63016-63017 [E6-18014]
Download as PDF
63016
Federal Register / Vol. 71, No. 208 / Friday, October 27, 2006 / Notices
indicated in the table, the average
burden per response for the NPIN Web
site User survey is 13 minutes and for
the NPIN Products and Services User
survey, 15 minutes. This differential is
due to the difference in survey lengths.
The NPIN Web site User survey is
comprised of 25 questions and the NPIN
Products and Services User survey is
comprised of 28 questions. The ‘‘Other’’
category of respondents is comprised of
organizations that identified themselves
as ‘‘Other’’ or ‘‘Unknown’’ when
requesting products or services from
NPIN. There is no cost to the
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses
per
respondent
Average
burden per
response
(in hours)
All organizations .......................................
1,437
1
13/60
311
...................................................................
Social service organization ......................
Health services organization/hospital/clinic.
Community-based organization ................
Association/foundation .............................
Libraries/clearinghouse/resource center ..
Faith-based organization ..........................
Government agency .................................
Educational organization/institution ..........
International agency .................................
Correctional facilities/agency ....................
News/media ..............................................
Businesses/corporation ............................
General public ..........................................
Other .........................................................
1,437
224
680
....................
2
2
....................
15/60
15/60
311
112
340
291
52
40
133
352
671
85
85
32
101
394
1,437
2
2
2
2
2
2
2
2
2
2
2
2
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
146
26
20
67
176
336
43
43
16
51
197
719
Subtotal ..............................................
...................................................................
4,577
....................
....................
2,292
Total ............................................
...................................................................
6,014
....................
....................
2,603
Form
Respondents
NPIN Web site User Survey .....................
Subotal ...............................................
NPIN Products and Services User Survey
Dated: October 23, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control Prevention.
[FR Doc. E6–18013 Filed 10–26–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–07–05CG]
jlentini on PROD1PC65 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
VerDate Aug<31>2005
17:11 Oct 26, 2006
Jkt 211001
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Medical Monitoring Project (MMP)—
New—National Center for HIV, STD and
TB Prevention (NCHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
This proposed data collection
supplements the HIV/AIDS surveillance
programs in 26 selected State and local
health departments, which collect
information on persons diagnosed with,
living with, and dying from HIV
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Total
burden
hours
infection and AIDS and will incorporate
data elements from two data collections:
Supplement to HIV/AIDS Surveillance
(SHAS) project (0920–0262) and the
Adult/Adolescent Spectrum of HIV
Disease (ASD). Both projects stopped
data collection in 2004.
Although CDC receives surveillance
data from all U.S. States, these
supplemental surveillance data are
needed to make estimates of key
indicators, such as quality of HIVrelated ambulatory care and the severity
of need for HIV-related care and
services. A large number of cities and
States are heavily impacted by the HIV/
AIDS epidemic, resulting in the need for
population-based national estimates of
HIV-related behaviors, clinical
outcomes, and quality of HIV care.
This project will collect data on
behaviors and clinical outcomes from a
probability sample of HIV-infected
adults receiving care in the U.S.
Collection of data from interviews with
HIV-infected patients will provide
information on patient demographics,
and the current levels of behaviors that
may facilitate HIV transmission: Sexual
and drug use behaviors; patients’ access
to, use of and barriers to HIV-related
secondary prevention services;
utilization of HIV-related medical
E:\FR\FM\27OCN1.SGM
27OCN1
63017
Federal Register / Vol. 71, No. 208 / Friday, October 27, 2006 / Notices
services; and adherence to drug
regimens. Collection of data from
patient medical records will provide
information on: Demographics and
insurance status; the prevalence and
incidence of AIDS-defining
opportunistic illnesses and comorbidities related to HIV disease; the
receipt of prophylactic and
antiretroviral medications; and whether
patients are receiving screening and
treatment according to Public Health
Service guidelines. No other Federal
agency collects national populationbased behavioral and clinical
information from HIV-infected adults in
care. The data will have significant
implications for policy, program
development, and resource allocation at
the State/local and national levels.
CDC is requesting approval for a 3year clearance for data collection. Data
will be collected by 26 Reporting Areas
(19 States, Puerto Rico and 6 separately
funded cities). CDC estimates an average
of 400 respondents per site with an 80%
response rate, resulting in 8,320
respondents for the interview portion. A
Short interview will be used for patients
who are too ill to complete the Standard
interview or when the interview must
be translated, and a Proxy interview will
be available if the patient consents to
having a family member or other person
answer the questions in the case of
severe illness or in the event the
selected participant died prior to being
interviewed. The proxy and the short
interview, each which will be used on
approximately 2% of patients, will take
approximately 20 minutes. Participation
of respondents is voluntary and there is
no cost to the respondents other than
their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Types of data collection
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
hours
Standard interview ...................................................................................................
Short interview .........................................................................................................
Proxy interview ........................................................................................................
7,988
166
166
1
1
1
45/60
20/60
20/60
5,991
55
55
Total ..................................................................................................................
........................
........................
........................
6,101
Dated: October 23, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–18014 Filed 10–26–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Portfolio Review on
Birth Defects and Developmental
Disabilities
jlentini on PROD1PC65 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel: Portfolio Review on Birth Defects and
Developmental Disabilities.
Times and Dates:
8:30 a.m.–4:30 p.m., January 8, 2007
(Closed).
8 a.m.–5 p.m., January 9, 2007 (Closed).
Place: CDC Harkin Global Communications
Center, 1600 Clifton Road, Atlanta, GA
30333.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
VerDate Aug<31>2005
16:53 Oct 26, 2006
Jkt 211001
Matters To Be Discussed: The meeting will
include the review of the Division of Birth
Defects and Developmental Disabilities’
programs, strategies, and activities.
Contact Person for More Information:
Esther Sumartojo, Associate Director for
Science, National Center on Birth Defects and
Developmental Disabilities, CDC, 1600
Clifton Road, NE., Mailstop E–87, Atlanta,
GA 30333, Telephone Number 404.498.3072.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: October 20, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–18005 Filed 10–26–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry
The Program Peer Review
Subcommittee of the Board of Scientific
Counselors (BSC), Centers for Disease
Control and Prevention (CDC), National
Center for Environmental Health/
Agency for Toxic Substances and
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Disease Registry (NCEH/ATSDR):
Teleconference.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC, NCEH/ATSDR
announces the following subcommittee
meeting:
Name: Program Peer Review Subcommittee
(PPRS).
Time and Date: 8:30 a.m.–10:30 a.m.
Eastern Standard Time, November 22, 2006.
Place: The teleconference will originate at
NCEH/ATSDR in Atlanta, Georgia. To
participate, dial 877/315–6535 and enter
conference code 383520.
Purpose: Under the charge of the BSC,
NCEH/ATSDR, the PPRS will provide the
BSC, NCEH/ATSDR with advice and
recommendations on NCEH/ATSDR program
peer review. They will serve the function of
organizing, facilitating, and providing a longterm perspective to the conduct of NCEH/
ATSDR program peer review.
Matters To Be Discussed: A review of the
previous meeting; an update on the planning
of the Site Specific Activities Peer Review; a
discussion of the revised Peer Review
Conflict-of-Interest form; a discussion of
Terrorism Preparedness and Emergency
Response Peer Review in February 2007:
Divisions included in the review, areas of
expertise required for the review, and
nominations for a PPRS panel member,
chairperson and peer reviewers.
Agenda items are subject to change as
priorities dictate.
This
meeting is scheduled to begin at 8:30
a.m. Eastern Standard Time. To
participate, please dial 877/315–6535
and enter conference code 383520.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\27OCN1.SGM
27OCN1
Agencies
[Federal Register Volume 71, Number 208 (Friday, October 27, 2006)]
[Notices]
[Pages 63016-63017]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-18014]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-07-05CG]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Medical Monitoring Project (MMP)--New--National Center for HIV, STD
and TB Prevention (NCHSTP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
This proposed data collection supplements the HIV/AIDS surveillance
programs in 26 selected State and local health departments, which
collect information on persons diagnosed with, living with, and dying
from HIV infection and AIDS and will incorporate data elements from two
data collections: Supplement to HIV/AIDS Surveillance (SHAS) project
(0920-0262) and the Adult/Adolescent Spectrum of HIV Disease (ASD).
Both projects stopped data collection in 2004.
Although CDC receives surveillance data from all U.S. States, these
supplemental surveillance data are needed to make estimates of key
indicators, such as quality of HIV-related ambulatory care and the
severity of need for HIV-related care and services. A large number of
cities and States are heavily impacted by the HIV/AIDS epidemic,
resulting in the need for population-based national estimates of HIV-
related behaviors, clinical outcomes, and quality of HIV care.
This project will collect data on behaviors and clinical outcomes
from a probability sample of HIV-infected adults receiving care in the
U.S. Collection of data from interviews with HIV-infected patients will
provide information on patient demographics, and the current levels of
behaviors that may facilitate HIV transmission: Sexual and drug use
behaviors; patients' access to, use of and barriers to HIV-related
secondary prevention services; utilization of HIV-related medical
[[Page 63017]]
services; and adherence to drug regimens. Collection of data from
patient medical records will provide information on: Demographics and
insurance status; the prevalence and incidence of AIDS-defining
opportunistic illnesses and co-morbidities related to HIV disease; the
receipt of prophylactic and antiretroviral medications; and whether
patients are receiving screening and treatment according to Public
Health Service guidelines. No other Federal agency collects national
population-based behavioral and clinical information from HIV-infected
adults in care. The data will have significant implications for policy,
program development, and resource allocation at the State/local and
national levels.
CDC is requesting approval for a 3-year clearance for data
collection. Data will be collected by 26 Reporting Areas (19 States,
Puerto Rico and 6 separately funded cities). CDC estimates an average
of 400 respondents per site with an 80% response rate, resulting in
8,320 respondents for the interview portion. A Short interview will be
used for patients who are too ill to complete the Standard interview or
when the interview must be translated, and a Proxy interview will be
available if the patient consents to having a family member or other
person answer the questions in the case of severe illness or in the
event the selected participant died prior to being interviewed. The
proxy and the short interview, each which will be used on approximately
2% of patients, will take approximately 20 minutes. Participation of
respondents is voluntary and there is no cost to the respondents other
than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total
Types of data collection respondents responses per response (in burden
respondent hours) hours
----------------------------------------------------------------------------------------------------------------
Standard interview................................... 7,988 1 45/60 5,991
Short interview...................................... 166 1 20/60 55
Proxy interview...................................... 166 1 20/60 55
----------------------------------------------------------
Total............................................ .............. .............. .............. 6,101
----------------------------------------------------------------------------------------------------------------
Dated: October 23, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-18014 Filed 10-26-06; 8:45 am]
BILLING CODE 4163-18-P